Metalloproteinases (MTP) are enzymes that degrade the extracellular ma
trix, mainly collagen tissue. Normally these enzymes are expressed in
vascular walls as proenzyme together with inhibitors of the active enz
ymes. By effect of different citokines, produced by an inflammatory pr
ocess in the vascular wall, these proenzymes are activated to an exten
t that surpasses the action of the inhibitors and degrade collagen. Th
is action may partly explain the rupture of atherosclerotic plaques ('
'vulnerability'') and also the remodelling of the vessel wall with ''c
ompensatory enlargement'' of the vessel (increase in the outer size of
the vessel) that allows the plaques to develop inside the arterial wa
ll without protruding into the vessel lumen for many years. The occlus
ion of safenous vein in aortocoronary bypass grafts is due to fibromus
cular proliferation and atheroma development and therefore the partici
pation of MTP in the occlusion of these vessels is a reasonable hypoth
esis. However, the structural features of safenous vein bypass grafts
are different from those of atheroma in native coronary arteries. Main
ly the compensatory enlargement of the vessels does not occur because
of intense fibrous tissue development including the adventitia and the
refore the new tissue in the wall is forced to protrude into the vesse
l lumen. The reason for this difference in the vessel wall remodeling
is not clear and the article by Grez et al in this tissue of this Jour
nal is an starting and promising study in this regard.